Listed by the USPTO as ABBAS, ABDULRAHMAN MUSTAFA
Tech Center 1600 • Art Units: 1612 1623 1627
This examiner grants 51% of resolved cases
ABBAS, ABDULRAHMAN MUSTAFA works in tech center 1600 and art unit 1612. Among 69 resolved cases, the allowance rate is 50.7%, the interview lift is 30.4%, and the median time to allowance is 1205 days. The listed companies are The Procter & Gamble Company, Colgate-Palmolive Company, and Washington University.
EVENTIDE LAW LLC, FISH & RICHARDSON P.C. (TC), and FOLEY & LARDNER LLP are the listed firms. The allowance rate is close to an even division of outcomes, while the 30.4% interview lift provides a significant prosecution signal within this record. The 1205-day median indicates that applicants should account for a lengthy path to allowance. With 69 resolved cases, the profile offers more context than a very small sample, but counsel should still treat the figures as examiner-specific guidance rather than a complete measure of every application.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18911401 | ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID | Non-Final OA | The Procter & Gamble Company |
| 18733216 | SKIN CARE COMPOSITION AND METHOD FOR TREATING POST-ACNE MARKS | Final Rejection | The Procter & Gamble Company |
| 18087423 | CHEMOEMBOLIC COMPOSITIONS AND METHODS OF TREATMENT USING THEM | Non-Final OA | Boston Scientific Medical Device Limited |
| 18704746 | IMPROVED FORMULATIONS OF PERSONAL CARE PRODUCTS FOR MASKING ODOR OR REDUCING PERSPIRATION | Final Rejection | CARGILL, INCORPORATED |
| 17776186 | LIPOSOME COMPOSITIONS AND METHODS OF TREATMENT TARGETED TO TUMOR ENDOTHELIUM | Non-Final OA | Washington University |
| 18270914 | METHODS AND MATERIALS FOR TREATING HAIR LOSS | Final Rejection | The Penn State Research Foundation |
| 18263262 | METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A POST-TREATMENT AGENT | Final Rejection | Henkel AG & Co. KGaA |
| 17627273 | ENTERIC PROTON PUMP INHIBITOR SOFTGEL CAPSULE | Non-Final OA | R.P. Scherer Technologies, LLC |
| 18091009 | CLEANSING COMPOSITIONS AND METHODS FOR USE | Non-Final OA | L'Oreal |
| 18255964 | TWO-PHASE COSMETIC COMPOSITION COMPRISING AN AMINO ACID AND TWO SPECIFIC ACIDS | Final Rejection | L’OREAL |
| 18544750 | PERSONAL CARE COMPOSITIONS | Non-Final OA | Colgate-Palmolive Company |
| 17309387 | Personal Care Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18693110 | FRAGRANCE COMPOSITIONS WITH MOISTURIZING BENEFITS | Non-Final OA | Firmenich SA |
| 18832577 | METHOD OF CONTROLLING FUNGI | Non-Final OA | UPL EUROPE LTD |
| 18577534 | NOVEL USE OF POLYMER COMBINATION | Final Rejection | Reckitt Benckiser Health Limited |
| 18454177 | METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | Final Rejection | KARUNA THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy50.7% of resolved applications examined by Abdulrahman Mustafa Abbas were allowed (69 resolved cases), compared with 40.6% across Art Unit 1612 over the last five years.
This examiner's interview lift is +30.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Abdulrahman Mustafa Abbas took 1,205 days on average from filing to allowance.
Abdulrahman Mustafa Abbas examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).